United States · FDA National Drug Code directory
lamivudine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62135-706_472f29d3-cf7e-0a76-e063-6294a90a9e7a
- Product NDC
- 62135-706
- Form
- SOLUTION
- Composition / generic term
- lamivudine oral
- Labeler
- Chartwell RX, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141031
- Source listing expiry
- 20261231
Source-listed ingredients
- LAMIVUDINE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TRAY in 1 BOX (62135-706-24) / 10 CUP in 1 TRAY / 30 mL in 1 CUP (62135-706-30) · 62135-706-24
- 240 mL in 1 BOTTLE, PLASTIC (62135-706-37) · 62135-706-37
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →